Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Chinook Therapeutics (KDNY)

Annual Return

Over the past 3 years, KDNY has had an average annual return of +60.25%, outperforming the benchmark SPY, which returned +4.73% annual.

Over the past 5 years, KDNY has had an average annual return of +49.58%, outperforming the benchmark SPY, which returned +4.12% annual.

Over the past 10 years, KDNY has had an average annual return of -5.06%, underperforming the benchmark SPY, which returned +12.95% annual.

Since Apr 15, 2015, KDNY has had an average annual return of -17.96%, underperforming the benchmark SPY, which returned +11.42% annual.

202320222021202020192018201720162015
+54.09%+60.62%+2.91%+168.68%-55.33%-64.78%-34.19%-59.49%-33.00%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023-3.61%-13.63%+6.06%-13.52%+20.88%+58.85%+1.97%+3.05%+54.09%
2022-20.98%-0.98%+28.13%-7.57%+0.42%+15.21%+5.76%+12.37%-5.45%+10.68%+4.15%+15.66%+60.62%
2021-10.60%+16.74%-6.09%+15.54%-8.07%-14.50%-7.74%+4.19%-5.88%-15.95%+49.12%+1.97%+2.91%
2020+42.35%+81.50%-10.19%+0.92%+18.39%-29.40%+22%+9.99%-21.54%+1.55%+13.27%+13.36%+168.68%
2019+12.88%+44.23%-7.42%+2.74%-20.53%-52.58%-14.44%-6.69%-13.99%+7.54%+4.43%-0.71%-55.33%
2018-16.01%-0.80%+48.79%-25.79%+27.51%-20.43%-16.44%+26.49%-0.68%-42.29%-41.58%+6.61%-64.78%
2017+3.94%-5.03%-4.44%-10.23%+3.61%+13.99%+12.75%-5.46%-12.34%-25.35%+19.49%-21.04%-34.19%

Drawdown analysis of Chinook Therapeutics (KDNY)

The maximum drawdown for the KDNY was -97.81%, occurring on Oct 24, 2019. This drawdown has not yet recovered.

The current KDNY drawdown is -81.13%.

Since Apr 15, 2015 KDNY has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-97.81%Apr 20, 20151138Oct 24, 2019OngoingOngoingOngoing
-6.19%Apr 15, 20151Apr 16, 20152Apr 20, 20153